B2M and melanoma: More interestingly, somatic loss of heterozygosity (LOH) at the HLA-I gene locus and mutations in B2M or at least one HLA-I gene (Figs. 4F, S4e) were both associated with higher NEO2IS in NSCLCs and melanomas.